SBIR/STTR Research Award

Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis

Award identifier df0fb2204ba082f8e602d123a5d87decd7fb4b2eb6a705ebff4babc261a0c942Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$149,475

Program and phase

SBIR · Phase I

Award year

2013

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DIAGNOSTIC PHOTONICS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
FNDNUZEMPST3
Solicitation number
PA12-195
Topic code
NIDCR

Research abstract

DESCRIPTION (provided by applicant): Diagnostic imaging in modern dental practice still relies mainly on visual inspection or x-ray radiography, a technology that remains largely unchanged since the late 1800s. The early detection of small caries and the evaluation of microscopic enamel cracks prior to facture are two major issues that may be addressed with the application of 3-D optical imaging techniques. Optical coherence tomography (OCT), an optical imaging technology that measures light reflections toform a 3-D image in much the same way that ultrasound measures sound reflections, is attractive for dental imaging because it permits the evaluation of microscopic tissue morphology at m-scale resolutions without the need for ionizing radiation or exogenous contrast. OCT is not yet ready for general use in dental practice, however, as it suffers from several technical constraints such as shallow imaging depth, slow speed, and the lack of practical commercial probes designed specifically for dental use. Inthis Phase I proposal, Diagnostic Photonics (DxP) will demonstrate that the technical innovations brought about by interferometric synthetic aperture microscopy (ISAM), the next-generation technology built on OCT, will overcome key shortcomings that have prevented the adoption of 3-D optical imaging technology in dental practice to date. We will perform ISAM imaging of ex vivo dental specimens with an existing DxP handheld ISAM probe system, quantitatively evaluate the performance improvement over conventional OCT, develop improved ISAM algorithms and optical configurations for extreme depth-of-field dental imaging, and design a dedicated intraoral probe for use in Phase II. In future Phase II work, the dedicated handheld dental probe will be constructed andtested in an in vivo clinical investigation. Clinical studies will include the evaluation of diagnostic accuracy and repeatability of caries identification, differentiation between active and inactive caries, enamel crack identification, and crack size measurement. These studies will also evaluate the reliability of the system and reproducibility of the results. The clinical, engineering, and business experts at DxP have a demonstrated track record of successfully implementing innovative medical imaging technologies and introducing them into clinical practice. This track record, when combined with the enabling technology of ISAM, yields a significant new opportunity to improve dental care through technical innovation. PUBLIC HEALTH RELEVANCE PUBLIC HEALTH RELEVANCE: In this Phase I project, we will investigate the use of interferometric synthetic aperture microscopy (ISAM), the next generation of optical imaging beyond optical coherence tomography (OCT), for the detection and evaluation of dentalcaries and cracks ex vivo. We will develop innovative new ISAM algorithms and optical hardware to extend the usable imaging depth-of-field by up to an order of magnitude over conventional OCT. Finally, we will apply our demonstrated expertise in optical and software engineering to the design of a dedicated handheld intraoral ISAM probe intended for in vivo clinical use.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

6 SBIR/STTR records share this UEI (2012–2014). Reported award amounts total $3,648,916. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.